Snap-8

Snap-8, also known as Acetyl Octapeptide-3 (SNAP-8, sequence: Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2), is a synthetic octapeptide designed to reduce the appearance of expression lines and wrinkles through a mechanism analogous to botulinum toxin but without the paralytic effects. Snap-8 is an elongated version of the hexapeptide Argireline (Acetyl Hexapeptide-3), with the addition of two amino acids that increase its binding affinity and clinical efficacy. It is classified as a neuropeptide cosmeceutical and represents a topical/injectable alternative to neurotoxin-based wrinkle treatment.

Snap-8 functions by competitively inhibiting the SNARE complex — the molecular machinery responsible for neurotransmitter vesicle fusion at the neuromuscular junction. The SNARE complex consists of three proteins (SNAP-25, syntaxin, and VAMP/synaptobrevin) that must assemble to enable acetylcholine release from motor neurons. Snap-8 mimics the N-terminal sequence of SNAP-25, competing for binding sites on the SNARE complex and reducing (but not eliminating) its assembly efficiency. This decreases acetylcholine release at the neuromuscular junction, resulting in mild relaxation of facial muscles — particularly the repetitive contraction patterns that create expression lines around the eyes (crow's feet), forehead (horizontal lines), and between the brows (glabellar lines). Unlike botulinum toxin, Snap-8 modulates rather than blocks neuromuscular transmission, preserving natural facial expression.

Research on Snap-8 demonstrates measurable reductions in wrinkle depth and skin roughness. Clinical studies using topical application at 3-10% concentration showed wrinkle depth reductions of 35-63% over 28 days, with the octapeptide (Snap-8) outperforming the hexapeptide (Argireline) by approximately 30% in direct comparison studies. The compound also shows improvements in skin smoothness and texture metrics beyond the direct wrinkle-relaxation effect, suggesting secondary benefits on dermal matrix organization.

Snap-8 is suited for researchers investigating non-invasive wrinkle reduction, SNARE complex biology, neuromuscular modulation, and cosmeceutical peptide development. It offers a unique mechanism of action in the beauty peptide space — neuromodulation rather than structural repair.

The 50mg vial provides substantial supply for both injectable and topical research applications. For injectable research, reconstitute with 2-5ml bacteriostatic water and administer via superficial subcutaneous injection in target facial areas at 50-200mcg per site. For topical research, dissolve in appropriate carrier solutions at 3-10% concentration. Snap-8 has a short half-life when injected, but its SNARE complex inhibition persists beyond clearance. Store at 2-8C after reconstitution. Effects are cumulative and typically become noticeable after 2-4 weeks of consistent application.

---

## Hormone & Reproductive